Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Hippieslayer who wrote (18779)	4/7/1998 11:47:00 AM
From: RXGOLF	Read Replies (1) \| Respond to of 32384

Now down 9/16. Better than most I own. (:- ) RXGOLF

To: Hippieslayer who wrote (18779)	4/7/1998 9:49:00 PM
From: John O'Neill	Read Replies (1) \| Respond to of 32384

Henry, FUGAZT and toynt...LGND has taken a "quantum" leap this year. The proximity of LGND NDA's is closer (and so is the prospect of earnings) that it was a couple of years ago. Also, public awareness is higher of the potential of drug solutions with new tech. LGND may consolidate for a while (it can't go to $14 because I just bt today at 14 15/16)...but as long as their drugs work (this is the key) the stock will take off this year. Henry..how confident can you be that LGND's drugs will work. The chart doesn't look like skepticism on drug efficacy. Just now CNBC stated LLY osteo drug may work on breast CA. How key is the role of LGND here..what is the $$potential to LGND by combining. JO